Collection: MUC1

MUCIN1 (MUC1) glycopeptides are specific components of the MUC1 glycoprotein, known for their heavily glycosylated structure. In medicine, MUC1 glycopeptides are promising targets for cancer immunotherapy due to their overexpression and altered glycosylation in various cancers, including breast, ovarian, pancreatic, liver, colon and lung cancers. Research efforts focus on developing MUC1 glycopeptide-based vaccines to elicit immune responses against tumor cells displaying aberrant MUC1 glycosylation, aiming to improve cancer treatment outcomes through targeted immunotherapeutic approaches.

Interested in Custom Synthesis?

Require a personalized glycopeptide or peptide sequence, or specific modifications? Explore our tailored synthesis services, precisely designed to meet your unique requirements.